The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Hidefumi Sasaki

Department of Oncology

Immunology and Surgery

Nagoya City University

Graduate School of Medical Sciences

Japan

[email]@med.nagoya-cu.ac.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Oncology, Immunology and Surgery, Nagoya City University, Graduate School of Medical Sciences, Japan. 2010 - 2012
  • Department of Surgery II, Nagoya City University Medical School, Nagoya, Japan. 2001 - 2010
  • Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, USA. 2003

References

  1. Overexpression of GLUT1 correlates with Kras mutations in lung carcinomas. Sasaki, H., Shitara, M., Yokota, K., Hikosaka, Y., Moriyama, S., Yano, M., Fujii, Y. Mol. Med. Report (2012) [Pubmed]
  2. Increased FGFR1 copy number in lung squamous cell carcinomas. Sasaki, H., Shitara, M., Yokota, K., Hikosaka, Y., Moriyama, S., Yano, M., Fujii, Y. Mol. Med. Report (2012) [Pubmed]
  3. MEK1 and AKT2 mutations in Japanese lung cancer. Sasaki, H., Hikosaka, Y., Kawano, O., Moriyama, S., Yano, M., Fujii, Y. J. Thorac. Oncol (2010) [Pubmed]
  4. CHRNA5 gene D398N polymorphism in Japanese lung adenocarcinoma. Sasaki, H., Hikosaka, Y., Okuda, K., Kawano, O., Yukiue, H., Yano, M., Fujii, Y. J. Surg. Res. (2010) [Pubmed]
  5. EGFR R497K polymorphism is a favorable prognostic factor for advanced lung cancer. Sasaki, H., Okuda, K., Shimizu, S., Takada, M., Kawahara, M., Kitahara, N., Okumura, M., Matsumura, A., Iuchi, K., Kawaguchi, T., Kubo, A., Kawano, O., Yukiue, H., Yano, M., Fujii, Y. J. Cancer Res. Clin. Oncol. (2009) [Pubmed]
  6. Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer. Sasaki, H., Shimizu, S., Okuda, K., Kawano, O., Yukiue, H., Yano, M., Fujii, Y. Lung. Cancer (2009) [Pubmed]
  7. EGFR polymorphism of the kinase domain in Japanese lung cancer. Sasaki, H., Endo, K., Takada, M., Kawahara, M., Tanaka, H., Kitahara, N., Matsumura, A., Iuchi, K., Kawaguchi, T., Okuda, K., Kawano, O., Yukiue, H., Yokoyama, T., Yano, M., Fujii, Y. J. Surg. Res. (2008) [Pubmed]
  8. AKT1 and AKT2 mutations in lung cancer in a Japanese population. Sasaki, H., Okuda, K., Kawano, O., Yukiue, H., Yano, M., Fujii, Y. Mol. Med. Report (2008) [Pubmed]
  9. A novel EGFR mutation D1012H and polymorphism at exon 25 in Japanese lung cancer. Sasaki, H., Okuda, K., Takada, M., Kawahara, M., Kitahara, N., Matsumura, A., Iuchi, K., Kawaguchi, T., Kubo, A., Endo, K., Kawano, O., Yukiue, H., Yano, M., Fujii, Y. J. Cancer Res. Clin. Oncol. (2008) [Pubmed]
  10. Epidermal growth factor receptor gene amplification and gefitinib sensitivity in patients with recurrent lung cancer. Sasaki, H., Endo, K., Okuda, K., Kawano, O., Kitahara, N., Tanaka, H., Matsumura, A., Iuchi, K., Takada, M., Kawahara, M., Kawaguchi, T., Yukiue, H., Yokoyama, T., Yano, M., Fujii, Y. J. Cancer Res. Clin. Oncol. (2008) [Pubmed]
  11. EGFR exon 20 insertion mutation in Japanese lung cancer. Sasaki, H., Endo, K., Takada, M., Kawahara, M., Kitahara, N., Tanaka, H., Okumura, M., Matsumura, A., Iuchi, K., Kawaguchi, T., Kawano, O., Yukiue, H., Yokoyama, T., Yano, M., Fujii, Y. Lung. Cancer (2007) [Pubmed]
  12. ErbB4 expression and mutation in Japanese patients with lung cancer. Sasaki, H., Okuda, K., Kawano, O., Endo, K., Yukiue, H., Yokoyama, T., Yano, M., Fujii, Y. Clin. Lung. Cancer (2007) [Pubmed]
  13. Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler. Sasaki, H., Okuda, K., Kawano, O., Endo, K., Yukiue, H., Yokoyama, T., Yano, M., Fujii, Y. Oncol. Rep. (2007) [Pubmed]
  14. Human MOB1 expression in non-small-cell lung cancer. Sasaki, H., Kawano, O., Endo, K., Suzuki, E., Yukiue, H., Kobayashi, Y., Yano, M., Fujii, Y. Clin. Lung. Cancer (2007) [Pubmed]
  15. CCND1 messenger RNA expression is correlated with EGFR mutation status in lung cancer. Sasaki, H., Okuda, K., Endo, K., Kawano, O., Yukiue, H., Yokoyama, T., Yano, M., Fujii, Y. Clin. Lung. Cancer (2007) [Pubmed]
  16. EGFRvIII mutation in lung cancer correlates with increased EGFR copy number. Sasaki, H., Kawano, O., Endo, K., Yukiue, H., Yano, M., Fujii, Y. Oncol. Rep. (2007) [Pubmed]
  17. EGFR and erbB2 mutation status in Japanese lung cancer patients. Sasaki, H., Shimizu, S., Endo, K., Takada, M., Kawahara, M., Tanaka, H., Matsumura, A., Iuchi, K., Haneda, H., Suzuki, E., Kobayashi, Y., Yano, M., Fujii, Y. Int. J. Cancer (2006) [Pubmed]
  18. Uncommon V599E BRAF mutations in Japanese patients with lung cancer. Sasaki, H., Kawano, O., Endo, K., Suzuki, E., Haneda, H., Yukiue, H., Kobayashi, Y., Yano, M., Fujii, Y. J. Surg. Res. (2006) [Pubmed]
  19. Right partial anomalous pulmonary venous connection found during lobectomy for coexisting lung cancer and tuberculosis: report of a case. Sasaki, H., Naka, N., Kitahara, N., Yoshikawa, S., Goto, M., Tamura, M., Tanaka, H., Okumura, M., Matsumura, A., Luchi, K. Clin. Lung. Cancer (2006) [Pubmed]
  20. Decreased fragile histidine triad gene messenger RNA expression in lung cancer. Sasaki, H., Haneda, H., Yukiue, H., Kobayashi, Y., Yano, M., Fujii, Y. Clin. Lung. Cancer (2006) [Pubmed]
  21. Decreased kallikrein 11 messenger RNA expression in lung cancer. Sasaki, H., Kawano, O., Endo, K., Suzuki, E., Haneda, H., Yukiue, H., Kobayashi, Y., Yano, M., Fujii, Y. Clin. Lung. Cancer (2006) [Pubmed]
  22. L858R EGFR mutation status correlated with clinico-pathological features of Japanese lung cancer. Sasaki, H., Endo, K., Takada, M., Kawahara, M., Kitahara, N., Tanaka, H., Okumura, M., Matsumura, A., Iuchi, K., Kawaguchi, T., Yukiue, H., Kobayashi, Y., Yano, M., Fujii, Y. Lung. Cancer (2006) [Pubmed]
  23. EGFR Mutation status in Japanese lung cancer patients: genotyping analysis using LightCycler. Sasaki, H., Endo, K., Konishi, A., Takada, M., Kawahara, M., Iuchi, K., Matsumura, A., Okumura, M., Tanaka, H., Kawaguchi, T., Shimizu, T., Takeuchi, H., Yano, M., Fukai, I., Fujii, Y. Clin. Cancer Res. (2005) [Pubmed]
  24. Decreased Hrad6B expression in lung cancer. Sasaki, H., Moriyama, S., Nakashima, Y., Yukiue, H., Fukai, I., Fujii, Y. Acta. Oncol (2004) [Pubmed]
  25. Histone deacetylase 1 mRNA expression in lung cancer. Sasaki, H., Moriyama, S., Nakashima, Y., Kobayashi, Y., Kiriyama, M., Fukai, I., Yamakawa, Y., Fujii, Y. Lung. Cancer (2004) [Pubmed]
  26. Arg and DAP3 expression was correlated with human thymoma stage. Sasaki, H., Ide, N., Yukiue, H., Kobayashi, Y., Fukai, I., Yamakawa, Y., Fujii, Y. Clin. Exp. Metastasis (2004) [Pubmed]
  27. Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer. Sasaki, H., Yu, C.Y., Dai, M., Tam, C., Loda, M., Auclair, D., Chen, L.B., Elias, A. Breast Cancer Res. Treat. (2003) [Pubmed]
  28. Cten mRNA expression was correlated with tumor progression in lung cancers. Sasaki, H., Moriyama, S., Mizuno, K., Yukiue, H., Konishi, A., Yano, M., Kaji, M., Fukai, I., Kiriyama, M., Yamakawa, Y., Fujii, Y. Lung. Cancer (2003) [Pubmed]
  29. Elevated serum epidermal growth factor receptor level is correlated with lymph node metastasis in lung cancer. Sasaki, H., Yukiue, H., Mizuno, K., Sekimura, A., Konishi, A., Yano, M., Kaji, M., Kiriyama, M., Fukai, I., Yamakawa, Y., Fujii, Y. Int. J. Clin. Oncol. (2003) [Pubmed]
  30. Angioarrestin mRNA expression in early-stage lung cancers. Sasaki, H., Moriyama, S., Sekimura, A., Mizuno, K., Yukiue, H., Konishi, A., Yano, M., Kaji, M., Fukai, I., Yamakawa, Y., Fujii, Y. Eur. J. Surg. Oncol (2003) [Pubmed]
  31. FHIT mRNA expression in thymoma. Sasaki, H., Yukiue, H., Kobayashi, Y., Yano, M., Fukai, I., Fujii, Y. Eur. J. Surg. Oncol (2003) [Pubmed]
  32. Cten mRNA expression is correlated with tumor progression in thymoma. Sasaki, H., Yukiue, H., Kobayashi, Y., Fukai, I., Fujii, Y. Tumour Biol. (2003) [Pubmed]
  33. Expression of the MTA1 mRNA in advanced lung cancer. Sasaki, H., Moriyama, S., Nakashima, Y., Kobayashi, Y., Yukiue, H., Kaji, M., Fukai, I., Kiriyama, M., Yamakawa, Y., Fujii, Y. Lung. Cancer (2002) [Pubmed]
  34. Decreased perioxisome proliferator-activated receptor gamma gene expression was correlated with poor prognosis in patients with lung cancer. Sasaki, H., Tanahashi, M., Yukiue, H., Moiriyama, S., Kobayashi, Y., Nakashima, Y., Kaji, M., Kiriyama, M., Fukai, I., Yamakawa, Y., Fujii, Y. Lung. Cancer (2002) [Pubmed]
  35. Beta IGH3, a TGF-beta inducible gene, is overexpressed in lung cancer. Sasaki, H., Kobayashi, Y., Nakashima, Y., Moriyama, S., Yukiue, H., Kaji, M., Kiriyama, M., Fukai, I., Yamakawa, Y., Fujii, Y. Jpn. J. Clin. Oncol. (2002) [Pubmed]
  36. Gene expression analysis of human thymoma correlates with tumor stage. Sasaki, H., Ide, N., Fukai, I., Kiriyama, M., Yamakawa, Y., Fujii, Y. Int. J. Cancer (2002) [Pubmed]
  37. Expression of the prothymosin alpha mRNA correlated with that of N-myc in neuroblastoma. Sasaki, H., Sato, Y., Kondo, S., Fukai, I., Kiriyama, M., Yamakawa, Y., Fujii, Y. Cancer Lett. (2001) [Pubmed]
  38. Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas. Sasaki, H., Dai, M., Auclair, D., Fukai, I., Kiriyama, M., Yamakawa, Y., Fujii, Y., Chen, L.B. Cancer (2001) [Pubmed]
  39. Serum level of the periostin, a homologue of an insect cell adhesion molecule, in thymoma patients. Sasaki, H., Dai, M., Auclair, D., Kaji, M., Fukai, I., Kiriyama, M., Yamakawa, Y., Fujii, Y., Chen, L.B. Cancer Lett. (2001) [Pubmed]
  40. Expression of the cdc25B gene as a prognosis marker in non-small cell lung cancer. Sasaki, H., Yukiue, H., Kobayashi, Y., Tanahashi, M., Moriyama, S., Nakashima, Y., Fukai, I., Kiriyama, M., Yamakawa, Y., Fujii, Y. Cancer Lett. (2001) [Pubmed]
  41. Expression of the sensitive to apoptosis gene, SAG, as a prognostic marker in nonsmall cell lung cancer. Sasaki, H., Yukiue, H., Kobayashi, Y., Moriyama, S., Nakashima, Y., Kaji, M., Fukai, I., Kiriyama, M., Yamakawa, Y., Fujii, Y. Int. J. Cancer (2001) [Pubmed]
  42. Expression of the MTA1 mRNA in thymoma patients. Sasaki, H., Yukiue, H., Kobayashi, Y., Nakashima, Y., Kaji, M., Fukai, I., Kiriyama, M., Yamakawa, Y., Fujii, Y. Cancer Lett. (2001) [Pubmed]
  43. Expression of the protein gene product 9.5, PGP9.5, is correlated with T-status in non-small cell lung cancer. Sasaki, H., Yukiue, H., Moriyama, S., Kobayashi, Y., Nakashima, Y., Kaji, M., Fukai, I., Kiriyama, M., Yamakawa, Y., Fujii, Y. Jpn. J. Clin. Oncol. (2001) [Pubmed]
 
WikiGenes - Universities